Adam J. Townsend, Chief Commercial Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 6,875 shares at $48.42 ($242K) on 2022-07-11, disclosed to the SEC on 2022-07-12.
Open-market sale of $242k APLS by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,875 | $0 | 0.0% |
| 2 | $48.42 | 5,000 | $242K | 100.0% |
| Total | $35.21 avg | 6,875 | $242K | 100% |
| Filing → |
| APLS | SELL | 2025-01-21 | $132K | — | Filing → |
| APLS | SELL | 2025-01-14 | $154K | — | Filing → |
| APLS | SELL | 2024-02-13 | $156K | — | Filing → |